Gilead Sciences GILD reported its Q3 earnings results on Thursday, October 28, 2021 at 04:01 PM.
Here's what investors need to know about the announcement.
Earnings
Gilead Sciences beat their estimated earnings by 52.3%, reporting an EPS of $2.65 versus an estimate of $1.74, which surprised analysts.
Revenue was up $844,000,000 from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.14, which was followed by a 2.21% drop in the share price the next day.
Here's a look at Gilead Sciences's past performance:
Quarter | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 |
---|---|---|---|---|
EPS Estimate | 1.73 | 2.09 | 2.15 | 1.95 |
EPS Actual | 1.87 | 2.08 | 2.19 | 2.11 |
Revenue Estimate | 6.07B | 6.74B | 7.33B | 6.39B |
Revenue Actual | 6.22B | 6.42B | 7.42B | 6.58B |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.